Should You Buy Moderna in March?
Moderna (NASDAQ: MRNA) has been one of the hottest stocks to buy over the past year, soaring more than 340% while the S&P 500 has increased by just 30% during that time. The company's COVID-19 vaccine has put Moderna on the map with investors, sending its market cap from less than $10 billion to more than $52 billion. And if its CEO is right about COVID-19 being around forever, the vaccine could deliver recurring income for many years.
However, Moderna's shares have been crashing over the past month despite a strong earnings report. Is March a good time to load up on the stock or should investors wait for more of a dip in price before investing in the company?
Image source: Getty Images.
Source Fool.com
